Our results indicated that the transplantation of HGF-M prevented the progression of peritoneal fibrosis and indicated that this novel gene therapy using macrophages may have potential for treating peritoneal fibrosis. The gene discussed is HGF; the disease is Peritoneal Fibrosis.